Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2009

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

vinorelbine tartrate

RADIATION

radiation therapy

Trial Locations (20)

NE63 9JJ

Wansbeck General Hospital, Ashington

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

GL53 7AN

Cheltenham General Hospital, Cheltenham

DE1 2QY

Derbyshire Royal Infirmary, Derby

DH1 5TW

University Hospital of North Durham, Durham

NE9 6SX

Queen Elizabeth Hospital, Gateshead

NE4 6BE

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

HA6 2RN

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood

NG5 1PB

Nottingham City Hospital NHS Trust, Nottingham

NG17 4JL

Kings Mill Hospital, Nottinghamshire

OX3 7LJ

Churchill Hospital, Oxford

S1O 2SJ

Cancer Research Centre at Weston Park Hospital, Sheffield

SN3 6BB

Great Western Hospital, Swindon

WR5 1DD

Worcester Royal Hospital, Worcester

BA21 4AT

Yeovil District Hospital, Yeovil

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

KA2 OBE

Crosshouse Hospital, Kilmarnock

CF14 2TL

Velindre Cancer Center at Velindre Hospital, Cardiff

CF64 2XX

Llandough Hospital, Llandough

NP9 2UB

Royal Gwent Hospital, Newport Gwent

Sponsors
All Listed Sponsors
lead

Medical Research Council

OTHER_GOV

NCT00253591 - Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter